Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
- Immunocytochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 19521-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#19521-1-AP, RRID:AB_10638144
- Product name
- NY-ESO-1 antibody
- Antibody type
- Polyclonal
- Description
- NY-ESO-1 antibody (Cat. #19521-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse and has been validated for the following applications: IF, IHC, IP, WB,ELISA.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Circulating tumor cells shielded with extracellular vesicle-derived CD45 evade T cell attack to enable metastasis.
STING agonist diABZI enhances the cytotoxicity of T cell towards cancer cells.
CD8+ T cell-Dependent Remodeling of the Tumor Microenvironment Overcomes Chemoresistance.
The IRENA lncRNA converts chemotherapy-polarized tumor-suppressing macrophages to tumor-promoting phenotypes in breast cancer.
Yang C, Wang X, To KKW, Cui C, Luo M, Wu S, Huang L, Fu K, Pan C, Liu Z, Fan T, Yang C, Wang F, Fu L
Signal transduction and targeted therapy 2024 Apr 5;9(1):84
Signal transduction and targeted therapy 2024 Apr 5;9(1):84
STING agonist diABZI enhances the cytotoxicity of T cell towards cancer cells.
Wang L, Liang Z, Guo Y, Habimana JD, Ren Y, Amissah OB, Mukama O, Peng S, Ding X, Lv L, Li J, Chen M, Liu Z, Huang R, Zhang Y, Li Y, Li Z, Sun Y
Cell death & disease 2024 Apr 13;15(4):265
Cell death & disease 2024 Apr 13;15(4):265
CD8+ T cell-Dependent Remodeling of the Tumor Microenvironment Overcomes Chemoresistance.
Lao L, Zeng W, Huang P, Chen H, Jia Z, Wang P, Huang D, Chen J, Nie Y, Yang L, Wu W, Liu J
Cancer immunology research 2023 Mar 1;11(3):320-338
Cancer immunology research 2023 Mar 1;11(3):320-338
The IRENA lncRNA converts chemotherapy-polarized tumor-suppressing macrophages to tumor-promoting phenotypes in breast cancer.
Liu J, Lao L, Chen J, Li J, Zeng W, Zhu X, Li J, Chen X, Yang L, Xing Y, Chen F, Huang D, Zhang X, Wei W, Gong C, Huang S, Yu Z, Li Z, Yang L, Liu J, Liu X, Zheng Q, Meng X, Liang J, Sun L, Zeng M, Li M, Liu Q, Su S, Song E
Nature cancer 2021 Apr;2(4):457-473
Nature cancer 2021 Apr;2(4):457-473
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- human testis tissue were subjected to SDS PAGE followed by western blot with 19521-1-AP(CTAG1A antibody) at dilution of 1:100
- Sample type
- tissue
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunofluorescent analysis of HepG2 cells, using CTAG1A antibody 19521-1-AP at 1:25 dilution and Rhodamine-labeled goat anti-rabbit IgG (red).
- Sample type
- cell line
